Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Shilliday, Ilona R ^a   Sherif, M ^b  

^a MONKLANDS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Calcium channel blockers *therapeutic use ; Humans; Kidney transplantation *adverse effects ; Kidney tubular necrosis, acute *prevention control ; Randomized controlled trials as topic

Indexed keywords

ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CYCLOSPORIN; CYCLOSPORIN A; DILTIAZEM; GALLOPAMIL; LACIDIPINE; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; PREDNISOLONE; PREDNISONE; STEROID; THYMOCYTE ANTIBODY; VERAPAMIL;

ACUTE KIDNEY TUBULE NECROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DIURESIS; DRUG DOSE REDUCTION; EDEMA; GLOMERULUS FILTRATION RATE; GRAFT VERSUS HOST REACTION; HEADACHE; HEART PALPITATION; HEMODIALYSIS; HLA SYSTEM; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPSIS; TACHYCARDIA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 44949232228     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003421.pub4     Document Type: Review

References (81)

1. Dawidson 1991 {published data only} Dawidson I, Rooth P, Lu C, Sagalowsky A, Diller K, Palmer B, et al.Verapamil improves the outcome after cadaver renal transplantation. Journal of the American Society of Nephrology 1991;2(5):983-90. [MEDLINE: 1760541].
2. Frei 1987 {published data only} *Frei U, Margreiter R, Harms A, Bosmuller C, Neumann KH, Viebahn R, et al.Preoperative graft reperfusion with a calcium antagonist improves initial function: preliminary results of a prospective randomized trial in 110 kidney recipients. Transplantation Proceedings 1987;19(5):3539-41. [MEDLINE: 3313853].
3. Harper 1997 {published data only} Harper SJ, Moorhouse J, Veitch PS, Bell PR, Horsburgh T, Walls J, et al.Improved immediate graft function with nifedipine in cyclosporine-treated renal allograft recipients - a randomized prospective study. Transplantation 1992;54(4):742-3. [MEDLINE: 1412770].
4. Harper SJ, Moorhouse J, Walls J, Veitch S, Bell PR, Donnelly J, et al.Protective effects of nifedipine in immediate and 6-month graft function in cyclosporin A treated renal allograft recipients [abstract]. Nephrology Dialysis Transplantation 1991;6(11):904.
5. Kuypers 2004 {published data only} Kuypers DR, Neumayer HH, Fritsche L, Budde K, Rodicio JL, Vanrenterghem Y. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study. Transplantation 2004;78(8):1204-11. [MEDLINE: 15502721].
6. Kuypers DR, Neumayer HH, Fritsche L, Budde K, Vanrenterghem Y. Calcium channel blockade and prevention of renal graft function deterioration in cyclosporine treated recipients: a multi-centre prospective, randomised , placebo controlled, 2 year study [abstract]. American Journal of Transplantation 2004;4(Suppl 8):432.
7. Ladefoged 1994 {published data only} Ladefoged SD, Pederson E, Hammer M, Rasmussen KC, Hansen FM, Andersen CB. Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study. Nephrology Dialysis Transplantation 1994;9(5):543-7. [MEDLINE: 8090335].
8. Lustig 1996 {published data only} Lustig S, Shmueli D, Boner G, Bar-Nathan N, Nakache R, Yussim A, et al.Gallopamil reduces the post-transplantation acute tubular necrosis in kidneys from aged donors. Israel Journal of Medical Sciences 1996;32(12):1249-51. [MEDLINE: 9007165].
9. Morales 1990 {published data only} Morales JM, Andres A, Alvarez C, Prieto C, Ortuno B, Ortuno T, et al.Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study. Transplantation Proceedings 1990;22(4):1733-5. [MEDLINE: 2389446].
10. Neumayer 1989 {published data only} Neumayer HH, Schreiber M, Wagner K. Prevention of delayed graft function by diltiazem and iloprost. Transplantation Proceedings 1989;21(1):1221-4. [MEDLINE: 2469225].
11. Neumayer HH, Wagner K. Prevention of delayed graft function in cadaver kidney transplants by diltiazem: outcome of two prospective, randomized clinical trials. Journal of Cardiovascular Pharmacology 1987;10 Suppl 10:S170-7. [MEDLINE: 2455126].
12. Wagner K, Albrecht S, Neumayer HH. Prevention of posttransplant acute tubular necrosis by the calcium antagonist diltiazem: a prospective randomized study. American Journal of Nephrology 1987;7(4): 287-91. [MEDLINE: 3318461].
13. Wagner K, Neumayer HH. Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6-month follow-up. Transplantation Proceedings 1987;19(1 Pt 2):1353-7. [MEDLINE: 3547865].
14. Neumayer 1992a {published data only} Neumayer HH, Kunzendorf U, Schreiber M. Protective effects of calcium antagonists in human renal transplantation. Kidney International - Supplement 1992;36:87-93. [MEDLINE: 1377295].
15. Neumayer HH, Kunzendorf U, Schreiber M. Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation. Renal Failure 1992;14(3):289-96. [MEDLINE: 1380721].
16. Neumayer 1992b {published data only} Neumayer HH, Kunzendorf U, Schreiber M. Protective effects of calcium antagonists in human renal transplantation. Kidney International - Supplement 1992;36:87-93. [MEDLINE: 1377295].
17. Neumayer HH, Kunzendorf U, Schreiber M. Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation. Renal Failure 1992;14(3):289-96. [MEDLINE: 1380721].
18. Oppenheimer 1992 {published data only} Alcaraz A, Oppenheimer F, Talbot-Wright R, Fernandez-Cruz L, Manalich M, Garcia-Pages E, et al.Effect of diltiazem in the prevention of acute tubular necrosis, acute rejection, and cyclosporine levels. Transplantation Proceedings 1991;23(5):2383-4. [MEDLINE: 1926395].
19. Oppenheimer F, Alcaraz A, Manalich M, Ricart MJ, Vilardell J, Campistol JM, et al.Influence of the calcium blocker diltiazem on the prevention of acute renal failure after renal transplantation. Transplantation Proceedings 1992;24(1):50-1. [MEDLINE: 1539339].
20. Tenschert 1991 {published data only} Tenschert W, Harfmann P, Meyer-Moldenhauer WH, Arndt R, Klosterhalfen H. Kidney protective effect of diltiazem after renal transplantation with long cold ischaemia time and triple-drug immunosuppression. Transplantation Proceedings 1991;23(1 Pt 2):1334-5. [MEDLINE: 1989231].
21. Wilkie 1994 {published data only} Wilkie ME, Beer JC, Evans S, Lord RH, Raferty M, Marsh FP. Prospective trial of oral nifedipine on early renal allograft function [abstract]. Nephrology Dialysis Transplantaion. 1993; Vol. 8:1053-4.
22. Wilkie ME, Beer JC, Evans SJ, Raftery MJ, Lord RH, Moore R, et al.A double-blind, randomized, placebo-controlled study of nifedipine on early renal allograft function. Nephrology Dialysis Transplantation 1994;9(7):800-4. [MEDLINE: 7970122].
23. Aros 2005 Aros CA, Schneider HO, Flores CA, Ardiles LG, Alruiz PA, Jerez V, et al.Correlation between C2 and AUC(0-4) in renal transplant patients treated with diltiazem. Transplantation Proceedings 2005;37(3): 1580-2. [MEDLINE: 15866679].
24. Barenbrock 1995 Barenbrock M, Breuer J, Schroder K, Wagner K, Neumayer HH, Rahn KH. A study of the nehroprotective effect of nitrendipine after renal transplantation [abstract]. XIIIth International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain). 1995:387.
25. Berg 1991 Berg KJ, Holdaas H, Endresen L, Fauchald P, Hartmaan A, Pran T, et al.Effects of isradipine on renal function in cyclosporin-treated renal transplanted patients.Nephrology Dialysis Transplantation 1991;6(10):725-30. [MEDLINE: 1836548].
26. Calo 2002 Calo L, Giacon B, Davis PA, Pagnin E, Piccin A, Riegler P, et al.Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine. Clinical Nephrology 2002;58(2):103-10. [MEDLINE: 12227681].
27. Chanard 2003 Chanard J, Toupance O, Lavaud S, Hurault de Ligny B, Bernaud C, Moulin B. Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients. Nephrology Dialysis Transplantation 2003;18(10):2147-53. [MEDLINE: 13679494].
28. Cuharadoglu 1993 Cuharadoglu S, Demirbas S, Haberal M. Results of verapamil treatment in 40 kidney transplant recipients [abstract]. Nephrology Dialysis Transplantation 1993;8:1038.
29. Dawidson 1989 Dawidson I, Rooth P, Fry WR, Sandor Z, Wilms C, Coorpender L, et al.Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil. Transplantation 1989;48(4):575-80. [MEDLINE: 2678635].
30. Dawidson 1992 Dawidson I, Lu C, Palmer B, Peters P, Rooth P, Risser R, et al.Verapamil (VP) improves the outcome after renal transplantation. Transplant International 1992;5 Suppl 1:S60-2. [MEDLINE: 14621733].
31. Donmez 1999 Donmez A, Karaaslan D, Sekerci S, Akpek E, Karakayali H, Arslan G. The effects of diltiazem and dopamine on early graft function in renal transplant recipients. Transplantation Proceedings 1999;31(8):3305-6. [MEDLINE: 10616487].
32. Duggan 1985 Duggan KA, MacDonald GJ, Charlesworth JA, Pussell BA. Verapamil prevents post-transplant oliguric renal failure. Clinical Nephrology 1985;24(6):289-91. [MEDLINE: 3907910].
33. el-Agroudy 2003 el-Agroudy AE, Hassan NA, Foda MA, Ismail AM, el-Sawy EA, Mousa O, et al.Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients. American Journal of Nephrology 2003;23(5):300-6. [MEDLINE: 12904684].
34. Ferguson 1990 Ferguson CJ, Hillis AN, Williams JD, Griffin PJ, Salaman JR. Calcium-channel blockers and other factors influencing delayed function in renal allografts. Nephrology Dialysis Transplantation 1990;5(9):816-20. [MEDLINE: 2129357].
35. Gossmann 2002 Gossmann J, Mondorf U, Dietz A, Kramer W, Kachel HG, Geiger H, et al.A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients. Transplantation Proceedings 2002;34(5):1767-70. [MEDLINE: 12176568].
36. Harper 1992 Harper SJ, Moorhouse J, Veitch PS, Horsburgh T, Walls J, Bell PR, et al.Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients. Transplant International 1992;5 Suppl 1:S69-72. [MEDLINE: 14621737].
37. Harper 1996 Harper SJ, Harris K, Jurewicz A, Walls J, Veitch P, Feehally J. Beneficial effects of oral nifedipine on cyclosporin (cya) treated renal allograft recipients - a randomised prospective study [abstract]. XIIIth International Congress of Nephrology; 1995 Jul 2-6;Madrid (Spain). 1995:381.
38. *Harper SJ, Moorhouse J, Abrams K, Jurewicz A, Nicholson M, Horsburgh T, et al.The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients - a randomised prospective study. Transplant International 1996;9(2):115-25. [MEDLINE: 8639252].
39. Kelly 1990 Kelly JJ, Walker RG, D'Apice AJ, Kincaid-Smith P. A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results.Transplantation Proceedings 1990;22(5):2127-8. [MEDLINE: 2219318].
40. Kumana 2003 Kumana CR, Tong MK, Li CS, Lauder IJ, Lee JS, Kou M, et al.Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin. British Journal of Clinical Pharmacology 2003;56(6):670-8. [MEDLINE: 14616428].
41. Lehtonen 2000 Lehtonen S, Isoniemi H, Salmela K. A randomised placebo controlled study on initial isradipine therapy in renal transplantation; long-term results [abstract]. Nephrology Dialysis Transplantation 2000;15(9):A276.
42. Madsen 1998 Madsen JK, Sorensen SS, Hansen HE, Pederson EB. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation. Nephrology Dialysis Transplantation 1998;13(9): 2327-34. [MEDLINE: 9761517].
43. McLaughlin 2005 McLaughlin GE, Abitol CL. Reversal of oliguric tacrolimus nephrotoxicity in children. Nephrology Dialysis Transplantation 2005;20(7):4171-5. [MEDLINE: 15840666].
44. McNally 1990 McNally PG, Walls J, Feehally J. The effect of nifedipine on renal function in normotensive cyclosporin-A-treated renal allograft recipients. Nephrology Dialysis Transplantation 1990;5(11):962-8. [MEDLINE: 2127834].
45. Midtvedt 1999 Midtvedt K, Hatmann A, Fauchald P, Sund S, Foss A, Nordal KP, et al.Nifedipine slow release reduces the incidence of acute rejections in hypertensive renal transplant recipients [abstract]. Nephrology Dialysis Transplanatation 1999;14(9):A308.
46. Midtvedt 2001 Midtveddt K, Hartmaan A, Foss A, Fauchald P, Nordal KP, Rootwelt K, et al.Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation 2001;72(11):1787-92. [MEDLINE: 11740389].
47. Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss A, et al.Reduction of left ventricular mass by lisinopril and nifedipine in hypertensive renal transplant recipients: a prospective randomized double-blind study. Transplantation 2001;72(1):107-11. [MEDLINE: 11468543].
48. Midtvedt kK, Hartmann A, Holdaas A, Fauchald P. Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double blind randomised comparative trial. Clinical Transplantation 2001;15(6):426-31. [MEDLINE: 11737121].
49. Parrott 1990 Parrott NR, Forsythe JL, Mathews JN, Lennard TWJ, Rigg KM, Proud G, et al.Late perfusion. A simple remedy for renal allograft primary nonfunction.Transplantation 1990;49(5):913-5. [MEDLINE: 2336708].
50. Pedersen 1995 Pedersen EB, Madsen JK, Kornerup HJ, Sorensen SS, Zachariae H. Ciclosporine nephrotoxicity can be counteracted by a calcium antagonist (felodipine) in acute and short-term studies [abstract]. Journal of the American Society of Nephrology 1995;6(3):1102.
51. Pedersen 1996 Pedersen EB, Madsen JK, Sorensen SS, Zachariae H. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies. Kidney International - Supplement 1996;55:94-6. [MEDLINE: 8743522].
52. Pirsch 1993 Pirsch JD, D'Alessandro AM, Roecker EB, Knechtle SJ, Reed A, Sollinger HW, et al.A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients. American Journal of Kidney Diseases 1993;21(2):189-95. [MEDLINE: 8430681].
53. Po 1994 Po C, Alvez L, Caldwell I, Raja R. Long term effects of calcium channel blockers on proteinuria in renal transplant patients on cyclosporine [abstract]. Journal of the American Society of Nephrology 1994;5(3):1030.
54. Propper 1989 Propper DJ, Whiting PH, Power DA, Edward N, Catto GR. The effect of nifedipine on graft function in renal allograft recipients treated with cyclosporin A. Clinical Nephrology 1989;32(2):62-7. [MEDLINE: 2670381].
55. Puig 1991 Puig JM, Lloveras J, Oliveras A, Costa A, Aubia J, Masramon J. Usefulness of diltiazem in reducing the incidence of acute tubular necrosis in Euro-Collins-preserved cadaveric renal grafts. Transplantation Proceedings 1991;23(5):2368-9. [MEDLINE: 1926388].
56. Santos 2002 Santos AF, Keitel E, Bittar A, Neto JP, Alves MD, Schaefer PG, et al.Long term results of diltiazem use associated to cyclosporin in renal transplantation. XIXth International Congress of the Transplantation Society; 2002 Aug 25-30; Miami (USA). 2002.
57. Scheuermann 1995 Scheuermann EH, Gossmann J, Peschke B, Kachel HG, Schoeppe W. A randomized, double blind, placebo controlled study of gallopamil in cyclosporine treated renal transplant recipients [abstract]. Journal of the American Society of Nephrology 1995;6(3):1114.
58. Schott 1994 Schott G, Prom T. Intraoperative cortical PO2 measurement in kidney transplantation. the effect of the calcium antagonist diltiazem. Urologe 1994;33(5):415-21. [MEDLINE: 7974930].
59. Sennesael 1996 Sennesael JJ, Lamote JG, Violet I, Tasse S, Verbeelen DL. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients. American Journal of Kidney Diseases 1996;27(5):701-8. [MEDLINE: 8629631].
60. Sobh 1989 Sobh MA, Shehab el-Din AB, Moustafa FE, el-Far MA, Hussein ME, Gad HM, et al.A prospective randomized study of the protective effect of verapamil on ischemic renal injury in renal allotransplants. Transplantation Proceedings 1989;21(1):1230-2. [MEDLINE: 2652404].
61. Sonzogni 1995 Sonzogni G, Perico N, Gaspari F, Amuchastegui CS, Ruggenenti P. Effect of calcium-channel blockade on renal hemodynamics and cyclosporine (csa) pharmacokinetcis in randomized double-blind dose-response study in stable renal allograft recipients [abstract]. Journal of the American Society of Nephrology 1995;6(3):1116.
62. van Riemsdijk 2000 van Riemsdijk IC, Mulder PG, de Fijter JW, Bruijn JA, van Hooff JP, Hoitsma AJ, et al.Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study. Transplantation 2000;70(1):122-6. [MEDLINE: 10919587].
63. Venkat 1995 Venkat Raman G, Griffin P, Moore R, Goodship T. Effects of amlodipine on renal function and cyclosporine pharmacokinetics in normotensive renal transplant recipients. XIIIth International Congress of Nephrology; 1995 Jul 2-6; Madrid (Spain). 1995:381.
64. Wahlberg 1992 Wahlberg J, Hanas E, Bergstrom C, Fellstrom B, Skarp-Orbeg I, Frodin L. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients. Transplantation Proceedings 1992;24(1):311-2. [MEDLINE: 1539291].
65. Frei 1990 Frei U, Harms A, Bakovic-Alt R, Pichlmayr R, Koch K. Calcium channel blockers for kidney protection. Journal of Cardiovascular Pharmacology 1990;16 Suppl 6:S11-5. [MEDLINE: 1707109].
66. ANZDATA 2000 Australian and New Zealand Society of Nephrology. Australian and New Zealand Dialysis and Transplant Registry. http://www.anzdata.org.au/anzdata/AnzdataReport/download.htm (accessed May 2000).
67. Asberg 1997 Asberg A, Christensen H, Hartmann A, Berg KJ. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1. Clinical Transplantation 1998;12(5):363-70. [MEDLINE: 9787942].
68. Chien 1980 Chien KR, Sherman SC, Mittnacht S Jr, Farber JL. Microsomal membrane structure and function subsequent to calcium activation of an endogenous phospholipase. Archives of Biochemistry & Biophysics 1980;205(2):614-22. [MEDLINE: 7469428].
69. Chrysostomou 1993 Chrysostomou A, Walker RG, Russ GR, d'Apice AJ, Knicaid-Smith P, Mathew TH. Diltiazem in renal allograft recipients receiving cyclosporine. Transplantation 1993;55(2):300-4. [MEDLINE: 8434380].
70. Dickersin 1994 Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309(6964):1286- 91. [MEDLINE: 7718048].
71. Egger 1997 Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315(7109):629-34. [MEDLINE: 9310563].
72. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency inmeta-analyses. BMJ 2003;327(7414):557- 60. [MEDLINE: 12958120].
73. Lefebvre 1996 Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia). 1996.
74. Mandreoli 1990 Mandreoli M, Esposti ED, Cocchi R, Fabbri A, Guerrini L, Fusaroli M. Do calcium channel blockers have any influence on the immunological status of renal graft recipients on ciclosporin therapy?. American Journal of Nephrology 1990;10(1):58-60. [MEDLINE: 1693039].
75. Matthys 1984 Matthys E, Patel Y, Kreisberg J, Stewart JH, Venkatachalam M. Lipid alterations induced by renal ischemia: pathogenic factor in membrane damage. Kidney International 1984;26(2):153-61. [MEDLINE: 6503134].
76. McCord 1985 McCord JM. Oxygen-derived free radicals in postischemic tissue injury. New England Journal of Medicine 1985;312(3):159-63. [MEDLINE: 2981404].
77. McMillen 1985 McMillen MA, Lewis T, Jaffe BM, Wait RB. Verapamil inhibition of lymphocyte proliferation and function in vitro. Journal of Surgical Research 1985;39(1):76-80. [MEDLINE: 3159937].
78. Morris 1998 Morris RG, Jones TE. Diltiazem disposition and metabolism in recipients of renal transplants. Therapeutic Drug Monitoring 1998;20(4):365-70. [MEDLINE: 9712457].
79. Nicholson 1996 Nicholson ML, Veitch PS, Bell PR. A prospective randomised study of the effect of nicardipine on ischaemic renal injury in renal allografts.Transplant International 1996;9(1):51-6. [MEDLINE: 8748411].
80. USRDS 2006 United States Renal Data System. www.usrds.org/atlas. htm(accessed April 2007).
81. Wilson 1984 Wilson DR, Arnold PE, Burke TJ, Schrier RW. Mitochondrial calcium accumulation and respiration in ischemic acute renal failure in the rat. Kidney International 1984;25(3):519-26. [MEDLINE: 6737843].